Daily Current Affairs for CAT, XAT & MBA GDPI – February 10, 2026
Indian Economy & Policy
Stock Market LIVE: GIFT Nifty hints at positive start amid strong cues; Asian markets extend gains
Sensex Today | Stock Market LIVE Updates: GIFT Nifty was trading at 25,985 levels, up by 95 points, indicating a positive start for Indian markets amid strong global cues
Bata India Q3 net profit up 12.6% at ₹66.1 cr, revenue rises 2.8%
It had posted a net profit of ₹58.7 crore in the previous October-December a year ago, according to a regulatory filing from Bata India
Indian Politics & Governance

Three-language panel submits report to Maharashtra government
Recommendations by the eight-member committee is not yet made public
Geopolitics (India Focus)
King Charles ‘ready to support’ U.K. police in ex-prince Andrew misconduct probe related to Epstein files
According to the BBC, emails released in the U.S. indicate Andrew forwarded reports to Epstein, including one from November 2010 sent by his then Indian-origin special assistant Amit Patel, related to official trade visits
Indian Stock Market & IPOs
Stock Market LIVE: GIFT Nifty hints at positive start amid strong cues; Asian markets extend gains
Sensex Today | Stock Market LIVE Updates: GIFT Nifty was trading at 25,985 levels, up by 95 points, indicating a positive start for Indian markets amid strong global cues
Bata India Q3 net profit up 12.6% at ₹66.1 cr, revenue rises 2.8%
It had posted a net profit of ₹58.7 crore in the previous October-December a year ago, according to a regulatory filing from Bata India
Marketing, Brands & Consumer Trends

Made in India, but what’s next? Pharma stalwarts debate the future
The occasion was the launch of Made in India, a biography of Lupin's late founder Desh Bandhu Gupta, chronicling his life and, through it, the rise of the Indian pharmaceutical industry itself.

HPV vaccines gain traction in India, though cost keeps reach limited
HPV, or human papillomavirus, is linked to several types of cancer, including cervical, anal, and throat cancers. India’s HPV vaccine market was worth ₹91 crore as of January 2026, on a moving annual total basis, according to pharma intelligence platform Pharmarack.
Sports (Business & Governance)

BCCI sticks to its policy, bars players from staying with families

Max O’Dowd faces abuse for dropping Pakistan’s Faheem Ashraf: ‘It seems Indian fans were angrier than Dutch supporters’